$3.33
1.83% today
Nasdaq, Aug 22, 04:49 pm CET
ISIN
US81728J1097
Symbol
SRTS

Sensus Healthcare, Inc. Stock price

$3.27
-1.33 28.91% 1M
-2.11 39.22% 6M
-3.65 52.75% YTD
-3.73 53.29% 1Y
-10.36 76.01% 3Y
+0.49 17.63% 5Y
-2.58 44.10% 10Y
-2.58 44.10% 20Y
Nasdaq, Closing price Thu, Aug 21 2025
+0.03 0.93%

Key metrics

Basic
Market capitalization
$53.8m
Enterprise Value
$34.7m
Net debt
positive
Cash
$19.1m
Shares outstanding
16.5m
Valuation (TTM | estimate)
P/E
29.7 | 29.1
P/S
1.4 | 1.2
EV/Sales
0.9 | 0.8
EV/FCF
7.5
P/B
1.0
Financial Health
Equity Ratio
89.8%
Return on Equity
11.9%
ROCE
4.8%
ROIC
3.8%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$39.5m | $43.6m
EBITDA
$3.0m | $5.1m
EBIT
$2.6m | $2.0m
Net Income
$1.8m | $1.9m
Free Cash Flow
$4.6m
Growth (TTM | estimate)
Revenue
24.7% | 4.3%
EBITDA
-47.6% | -40.3%
EBIT
-52.9% | -74.8%
Net Income
-61.3% | -72.2%
Free Cash Flow
200.7%
Margin (TTM | estimate)
Gross
56.0%
EBITDA
7.6% | 11.7%
EBIT
6.5%
Net
4.6% | 4.2%
Free Cash Flow
11.7%
More
EPS
$0.1
FCF per Share
$0.3
Short interest
5.5%
Employees
54
Rev per Employee
$770.0k
Show more

Is Sensus Healthcare, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Sensus Healthcare, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Sensus Healthcare, Inc. forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a Sensus Healthcare, Inc. forecast:

Buy
91%
Hold
9%

Financial data from Sensus Healthcare, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
39 39
25% 25%
100%
- Direct Costs 17 17
38% 38%
44%
22 22
16% 16%
56%
- Selling and Administrative Expenses 14 14
35% 35%
35%
- Research and Development Expense 5.90 5.90
69% 69%
15%
3.02 3.02
48% 48%
8%
- Depreciation and Amortization 0.46 0.46
44% 44%
1%
EBIT (Operating Income) EBIT 2.56 2.56
53% 53%
6%
Net Profit 1.80 1.80
61% 61%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Sensus Healthcare, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sensus Healthcare, Inc. Stock News

Neutral
GlobeNewsWire
about 18 hours ago
Investors can contact the law firm at no cost to learn more about recovering their losses
Neutral
Seeking Alpha
14 days ago
Sensus Healthcare, Inc. (NASDAQ:SRTS ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Javier Rampolla - Chief Financial Officer Joseph C. Sardano - Co-Founder, Chairman & CEO Michael J.
Neutral
The Motley Fool
15 days ago
Sensus (SRTS) Q2 Revenue Falls 21%
More Sensus Healthcare, Inc. News

Company Profile

Sensus Healthcare, Inc. operates as a medical device company, which provides treatments for both oncological and non-oncological skin conditions. The firm's portfolio of treatment devices includes the SRT-100, SRT-100+ and SRT-100 Vision. Its main product, superficial radiation therapy (SRT), a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers and other skin conditions such as keloids. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

Head office United States
CEO Joseph Sardano
Employees 54
Founded 2010
Website sensushealthcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today